Cargando…

Role of Gd(2)O(3)-doped carbon-11-choline-lenvatinib nanoparticles contrast agent PET/CT in the diagnosis of patients with lung cancer

Positron emission tomography-computed tomography (PET/CT) is an efficient method for the diagnosis of various types of human cancer. Studies have demonstrated that Gd(2)O(3)-doped carbon-11-choline (GdCho) can be used as a contrast nanoparticle for PET/CT in the diagnosis of patients with lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tong, Hang, Dongfang, Li, Ying, Zhang, Jin, Wu, Huayang, Wang, Hongyan, Tian, Enbing, Yan, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960386/ https://www.ncbi.nlm.nih.gov/pubmed/32002026 http://dx.doi.org/10.3892/ol.2019.11243

Ejemplares similares

Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020)

Dynamic (11)C-Choline PET / CT for the primary diagnosis of prostate cancer
por: Golan, Shay, et al.
Publicado: (2018)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Effect of positive carbon-11-choline PET/CT results in the therapeutic management of prostate cancer biochemical relapse
por: Gómez-de la Fuente, Francisco J., et al.
Publicado: (2019)

Facile Synthesis of Gd-Functionalized Gold Nanoclusters as Potential MRI/CT Contrast Agents
por: Le, Wenjun, et al.
Publicado: (2016)

Clinical Indications of (11)C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
por: Picchio, Maria, et al.
Publicado: (2012)

(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis
por: Chotipanich, Chanisa, et al.
Publicado: (2015)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Catechin tuned magnetism of Gd-doped orthovanadate through morphology as T(1)-T(2) MRI contrast agents
por: Vairapperumal, Tamilmani, et al.
Publicado: (2016)

COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT
por: Olivari, Laura, et al.
Publicado: (2020)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma
por: Okamura, Shusuke, et al.
Publicado: (2022)

Interpretation of 11C–choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer
por: Matti, A., et al.
Publicado: (2017)

The Role of [(18)F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [(11)C]Choline PET/CT and Histopathological Analysis
por: Zanoni, Lucia, et al.
Publicado: (2021)

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
por: Deijen, Charlotte L., et al.
Publicado: (2021)

The effects of three different contrast agents (Gd-BOPTA, Gd-DTPA, and Gd-DOTA) on brachial plexus magnetic resonance imaging
por: Zhang, Xiaojing, et al.
Publicado: (2021)

(11)C-choline vs. (18)F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma
por: Nanni, Cristina, et al.
Publicado: (2007)

Variability of Gross Tumor Volume in Nasopharyngeal Carcinoma Using (11)C-Choline and (18)F-FDG PET/CT
por: Jiang, Jun, et al.
Publicado: (2015)

Diagnostic performance of (11)C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancer
por: Kitajima, Kazuhiro, et al.
Publicado: (2017)

Locating hyperfunctioning parathyroid glands using (11)C-Choline PET/CT: an inter- and intra-observer variation study
por: Christensen, Julie Wulf, et al.
Publicado: (2021)

Prognostic Value of Metabolic Imaging Data of (11)C-choline PET/CT in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma
por: Donadon, Matteo, et al.
Publicado: (2021)

Use of [(11)C]choline PET/CT for visualization of four hyperactive parathyroid glands in a patient with renal hyperparathyroidism
por: Raitza, Matti, et al.
Publicado: (2022)

Imaging Comparison between (18)F-FDG-PET/CT and (18)F-Flouroethyl Choline PET/CT in Rare Case of Thymus Carcinoma Exhibiting a Positive Choline Uptake
por: Takesh, Mustafa, et al.
Publicado: (2013)

Gd-Si Oxide Nanoparticles as Contrast Agents in Magnetic Resonance Imaging
por: Cabrera-García, Alejandro, et al.
Publicado: (2016)

11C-choline PET/CT and whole-body MRI including diffusion-weighted imaging for patients with recurrent prostate cancer
por: Wieder, Hinrich, et al.
Publicado: (2017)

Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma
por: Hodolic, Marina
Publicado: (2010)

Synthesis and characterization of Gd(3+)-loaded hyaluronic acid-polydopamine nanoparticles as a dual contrast agent for CT and MRI scans
por: Shariati, Alireza, et al.
Publicado: (2023)

A liposomal Gd contrast agent does not cross the mouse placental barrier
por: Shetty, Anil N., et al.
Publicado: (2016)

Gd and Eu Co-Doped Nanoscale Metal–Organic Framework as a T(1)–T(2) Dual-Modal Contrast Agent for Magnetic Resonance Imaging
por: Wang, Geoffrey D., et al.
Publicado: (2016)

Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness
por: Chen, Ji, et al.
Publicado: (2012)

Evaluation of (11)C-choline PET/CT for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract: a pilot study
por: Sassa, Naoto, et al.
Publicado: (2014)

Comparison of 11C-choline Positron Emission Tomography/Computed Tomography (PET/CT) and Conventional Imaging for Detection of Recurrent Prostate Cancer
por: Kawanaka, Yusuke, et al.
Publicado: (2018)

Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT
por: Gergelis, Kimberly R., et al.
Publicado: (2019)

(18)F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature
por: Evangelista, Laura, et al.
Publicado: (2020)

Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review
por: Skanjeti, Andrea, et al.
Publicado: (2011)

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
por: Massaro, Arianna, et al.
Publicado: (2012)

Cerebellar Metastases from Prostate Cancer Detected by PET/CT with (18)F-Choline
por: Filippi, Luca, et al.
Publicado: (2022)

GdVO(4):Eu(3+),Bi(3+) Nanoparticles as a Contrast Agent for MRI and Luminescence Bioimaging
por: Zhu, Guannan, et al.
Publicado: (2019)

Metabolic Volumetric Parameters in (11)C-Choline PET/MR Are Superior PET Imaging Biomarkers for Primary High-Risk Prostate Cancer
por: Tseng, Jing-Ren, et al.
Publicado: (2018)

Biocompatible carbonized iodine-doped dots for contrast-enhanced CT imaging
por: Jeong, Yohan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uiq71ob1f3p6cghcea75dlakrl